ISSN: 2147-2092
Evaluation of the Effects of Recurrent Dexmedetomidine on Cognitive Functions and Brain Tissue in Streptozotocin-Induced Rats with Alzheimer's Disease
PDF
Cite
Share
Request
Original Investigation
VOLUME: 33 ISSUE: 1
P: 5-9
January 2022

Evaluation of the Effects of Recurrent Dexmedetomidine on Cognitive Functions and Brain Tissue in Streptozotocin-Induced Rats with Alzheimer's Disease

GMJ 2022;33(1):5-9
DOI: 10.12996/gmj.2022.02
Mustafa Arslan 1
Ayşegül Küçük 2
Merve Meryem Kıran 3
Zeynep Köksal 1
Ömer Kurtipek 1
Mustafa Kavutçu 4
1. Gazi University, Faculty of Medicine, Department of Anesthesiology of Reanimation, Ankara, Turkey
2. Kütahya Health Sciences University, Faculty of Medicine, Department of Physiology, Kütahya, Turkey
3. Yıldırım Beyazit University, Faculty of Medicine, Department of Medical Pathology, Ankara, Turkey
4. Gazi University, Faculty of Medicine, Department of Medical Biochemistry, Ankara, Turkey
No information available.
No information available
Received Date: 11.12.2019
Accepted Date: 24.01.2021
PDF
Cite
Share
Request

ABSTRACT

Conclusion:

We concluded that recurrent dexmedetomidine administration in rats treated with STZ positively affects cognitive functions evaluated with RAM in the presence of recurrent dexmedetomidine. Also histopathological and biochemical markers supported these findings. We concluded that observational studies should be performed in large series to correlate these results with clinical applications.

Results:

At the beginning, the number of The radial arm maze test (RAM) input-output is similar in all groups, but 3 weeks after the Alzheimer's formation RAM input-output decreased significantly. In Group AD, the number of RAM input-outputs increased significantly compared to Group A after 2nd and 3rd anesthesia applications. Glial fibrillary acidic protein levels were significantly higher in Group A compared to C and S groups in hippocampus tissue. In Group AD, it was found to be significantly lower than Group A. In group A Catalase (CAT) and Paraoxonase 1 (PON-1) activities and Thiobarbituric acid reactive substances (TBARS) level of brain tissue were found higher than Group C and S. TBARS levels of Group AD brain tissue was significantly lower than Group A.

Materials and Methods:

Totally 24 aged Wistar Albino rats were divided into 4 equal groups; control (Group C), sham (Group S), Alzheimer (Group A) and Alzheimer + dexmedetomidine (Group AD). All rats in Group A and Group AD received stereotaxic injection under ketamine (100 mg / kg, i.p.) anesthesia. Midline burr hole was entered under the dura. Group A and Group AD 3 mg/kg (10 ml) were induced by administering STZ experimental Alzheimer intracerebroventricularly. Four weeks after the surgery, Group S and Group AD received 100 μg/kg (i.p) dexmedetomidine for 3 consecutive days. Each group were tested with RAM test. After 24 hours, all rats were euthanized under anesthesia and brain tissue was taken. Hippocampus tissues were evaluated Biochemical and histopathologically.

Objective:

The aim of this study was to evaluate the effects of recurrent dexmedetomidine on cognitive functions and brain histopathology in the elderly rat model which has Alzheimer disease created with streptozocin (STZ).

Article is only available in PDF format. Show PDF
2024 ©️ Galenos Publishing House